Generation and Characterization of Stable Small Colony Variants of USA300 Staphylococcus aureus in RAW 264.7 Murine Macrophages
Authors:
- Dalida BivonaDBDalida Bivona
- Carmelo BonomoCBCarmelo Bonomo
- Lorenzo ColombiniLCLorenzo Colombini
- Paolo G. BonacciPaolo G. Bonacci
- Grete F. PriviteraGrete F. Privitera
- Giuseppe CarusoGiuseppe Caruso
- Filippo CaraciFCFilippo Caraci
- Francesco SantoroFSFrancesco Santoro
- Nicolò MussoNicolò Musso
- Dafne BongiornoDafne Bongiorno
- Francesco IannelliFrancesco Iannelli
- Stefania StefaniSSStefania Stefani
Open Access
- 16 March 2024
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 13 (3) , 264
Abstract
Intracellular survival and immune evasion are typical features of staphylococcal infections. USA300 is a major clone of methicillin-resistant S. aureus (MRSA), a community- and hospital-acquired pathogen capable of disseminating throughout the body and evading the immune system. Carnosine is an endogenous dipeptide characterized by antioxidant and anti-inflammatory properties acting on the peripheral (macrophages) and tissue-resident (microglia) immune system. In this work, RAW 264.7 murine macrophages were infected with the USA300 ATCC BAA-1556 S. aureus strain and treated with 20 mM carnosine and/or 32 mg/L erythromycin. Stable small colony variant (SCV) formation on blood agar medium was obtained after 48 h of combined treatment. Whole genome sequencing of the BAA-1556 strain and its stable derivative SCVs when combining Illumina and nanopore technologies revealed three single nucleotide differences, including a nonsense mutation in the shikimate kinase gene aroK. Gene expression analysis showed a significant up-regulation of the uhpt and sdrE genes in the stable SCVs compared with the wild-type, likely involved in adaptation to the intracellular milieu.Keywords
Funding Information
- Ministry of Research (MIUR) Italy (PRIN2020 CO-DICO PROGETTO 202089LLEH_002, 2014–2020 DM1062/2021, PE00000007, INF-ACT, RC2022-N4)
- European Union FSE-REACT-EU, PON Ricerca e Innovazione (PRIN2020 CO-DICO PROGETTO 202089LLEH_002, 2014–2020 DM1062/2021, PE00000007, INF-ACT, RC2022-N4)
- MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (PRIN2020 CO-DICO PROGETTO 202089LLEH_002, 2014–2020 DM1062/2021, PE00000007, INF-ACT, RC2022-N4)
- Italian Ministry of Health Research Program (PRIN2020 CO-DICO PROGETTO 202089LLEH_002, 2014–2020 DM1062/2021, PE00000007, INF-ACT, RC2022-N4)
This publication has 50 references indexed in Scilit:
- Staphylococcus aureusST228 and ST239 as models for expression studies of diverse markers during osteoblast infection and persistenceMicrobiologyopen, 2021
- Detection of methicillin‐resistant Staphylococcus aureus persistence in osteoblasts using imaging flow cytometryMicrobiologyopen, 2020
- Synergistic effect of vancomycin and l-homocarnosine alleviates Staphylococcus aureus-induced osteomyelitis in ratsBiomedicine & Pharmacotherapy, 2019
- Inside job: Staphylococcus aureus host-pathogen interactionsInternational Journal of Medical Microbiology, 2018
- Small colony variants of Staphylococcus aureus reveal distinct protein profilesProteomics, 2011
- Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infectionEMBO Molecular Medicine, 2011
- Small colony variants of Staphylococcus aureus — reviewFolia Microbiologica, 2010
- Inhibitory effect of carnosine and N-acetyl carnosine on LPS-induced microglial oxidative stress and inflammationPeptides, 2009
- Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureusInternational Journal of Medical Microbiology, 2007
- Influence of β-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacityAmino Acids, 2006